Advertisement
Heart, Lung and Circulation

An Audit of Lung Donor Pool: Optimal Current Donation Strategies and the Potential of Novel Time-Extended Donation After Circulatory Death Donation

      Background

      In Australia, increased organ donation and subsequent lung transplantation (LTx) rates have followed enhanced donor identification, referral and management, as well as the introduction of a donation after circulatory death (DCD) pathway. However, the number of patients waiting for LTx still continues to exceed the number of lung donors and the search for further suitable donors is critical.

      Methods

      All 2014–2018 Victorian DonateLife hospital deaths after intensive care unit (ICU) admission were analysed retrospectively to quantify unrecognised lung donors using current criteria, as well as novel time-extended (90 mins–24 hrs post-withdrawal) DCD lung donors.

      Results

      Using standard lung donor eligibility criteria, we identified 473 potential lung donors and a further 122 time-extended DCD potential lung donors among 3,538 patients meeting general eligibility criteria. Detailed review of end-of-life discussions with patient families and the reasons why they were not offered donation revealed several categories of additional lung donors–traditional lung donors missed in current practice (n=2); hepatitis C infected lung donors potentially treatable with direct-acting antivirals (n=14), time-extended DCD lung donors (n=60); donor lungs potentially suitable for transplant with use of ex-vivo lung perfusion (EVLP) (n=7).

      Conclusion

      While the number of lung donor opportunities missed under existing DonateLife donor identification and management processes was limited, a time-extended DCD lung donation pathway could substantially expand the lung donor pool. The use of hepatitis C infected donors, and the possibility of EVLP to solve donor graft assessment or logistic issues, could also provide small additional lung donor opportunities.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Australian Organ, Tissue Donation, Tranplantation Authority
        Annual report.
        (Available at:)
        • Australian Department of Health
        Review of the implementation of the national reform agenda on organ and tissue donation and transplantation 2017.
        (Available at:)
        • Snell G.I.
        • Westall G.P.
        • Oto T.
        Donor risk prediction: how 'extended' is safe?.
        Curr Opin Organ Transplant. 2013; 18: 507-512
        • Paraskeva M.A.
        • Levin K.C.
        • Westall G.P.
        • Snell G.I.
        Lung transplantation in Australia, 1986-2018: more than 30 years in the making.
        Med J Aust. 2018; 208: 445-450
        • Snell G.I.
        • Levvey B.J.
        • Henriksen A.
        • Whitford H.M.
        • Levin K.
        • Paraskeva M.
        • et al.
        Donor lung referrals for lung transplantation: a 'behind the scenes' view.
        Heart Lung Circ. 2020; 29: 793-799
      1. Australian and New Zealand Intensive Care Society. ANZICS Statement on Death and Organ Donation, Edition 4. 2019
        • Levvey B.
        • Keshavjee S.
        • Cypel M.
        • Robinson A.
        • Erasmus M.
        • Glanville A.
        • et al.
        Influence of lung donor agonal and warm ischemic times on early mortality: analyses from the ISHLT DCD Lung Transplant Registry.
        J Heart Lung Transplant. 2019; 38: 26-34
        • Transplantation Society of Australia and New Zealand
        Clinical Guidelines for Organ Transplantation from Deceased Donors (Version 1.3).
        2019
        • Reeb J.
        • Keshavjee S.
        • Cypel M.
        Successful lung transplantation from a donation after cardiocirculatory death donor taking more than 120 minutes to cardiac arrest after withdrawal of life support therapies.
        J Heart Lung Transplant. 2016; 35: 258-259
        • Pilcher D.
        • Gladkis L.
        • Arcia B.
        • Bailey M.
        • Cook D.
        • Cass Y.
        • et al.
        Estimating the number of organ donors in australian hospitals–implications for monitoring organ donation practices.
        Transplantation. 2015; 99: 2203-2209
        • European Committee on Organ Transplantation
        Guide to the quality and safety of Organs for Transplantation (7th Edition).
        2018
        • Snell G.I.
        • Levvey B.J.
        • Levin K.
        • Paraskeva M.
        • Westall G.
        Donation after brain death versus donation after circulatory death: lung donor management issues.
        Semin Respir Crit Care Med. 2018; 39: 138-147
        • Australian Government Organ and Tissue Authority
        National protocol for Donation after Cardiac Death.
        2010 (Available at:)
        • Woolley A.E.
        • Singh S.K.
        • Goldberg H.J.
        • Mallidi H.R.
        • Givertz M.M.
        • Mehra M.R.
        • et al.
        Heart and lung transplants from HCV-infected donors to uninfected recipients.
        N Engl J Med. 2019; 380: 1606-1617
        • Khan B.
        • Singer L.G.
        • Lilly L.B.
        • Chaparro C.
        • Martinu T.
        • Juvet S.
        • et al.
        Successful lung transplantation from hepatitis C positive donor to seronegative recipient.
        Am J Transplant. 2017; 17: 1129-1131
        • Rakhra S.S.
        • Opdam H.I.
        • Gladkis L.
        • Arcia B.
        • Fink M.A.
        • Kanellis J.
        • et al.
        Untapped potential in Australian hospitals for organ donation after circulatory death.
        Med J Aust. 2017; 207: 294-301
      2. International Registry of Organ Donation and Transplantation Newsletter 2017.
        (Available at:)
        • Scientific Registry of Transplant Recipients
        OPTN/SRTR 2017 Annual data report.
        (Available at:)
        • Kotecha S.
        • Hobson J.
        • Fuller J.
        • Paul E.
        • Levvey B.J.
        • Whitford H.
        • et al.
        Continued successful evolution of extended criteria donor lungs for transplantation.
        Ann Thorac Surg. 2017; 104: 1702-1709
        • Cypel M.
        • Yeung J.C.
        • Liu M.
        • Anraku M.
        • Chen F.
        • Karolak W.
        • et al.
        Normothermic ex vivo lung perfusion in clinical lung transplantation.
        N Engl J Med. 2011; 364: 1431-1440
        • Possoz J.
        • Neyrinck A.
        • Van Raemdonck D.
        Ex vivo lung perfusion prior to transplantation: an overview of current clinical practice worldwide.
        J Thorac Dis. 2019; 11: 1635-1650
        • Cypel M.
        • Yeung J.C.
        • Donahoe L.
        • Chen M.
        • Zamel R.
        • Hoetzenecker K.
        • et al.
        Normothermic ex vivo lung perfusion: does the indication impact organ utilization and patient outcomes after transplantation?.
        J Thorac Cardiovasc Surg. 2020; 159: 346-355